RS130-180

• Description:

  RS130-180 is a selective β-arrestin-biased agonist targeting the serotonin 2A receptor (5-HT2aR) . RS130-180 is promising for research of neuropsychiatric disorders such as depression[1].

• UNSPSC:

  12352211

• Target:

  5-HT Receptor

• Related Pathways:

  GPCR/G Protein; Neuronal Signaling

• Field of Research:

  Neurological Disease

• Smiles:

  C#CCOC1=C(C=CC=C1)CNCCC2=CC(OC)=C(C=C2OC)N(C)C

• Molecular Formula:

  C22H28N2O3

• Molecular Weight:

  368.47

• References & Citations:

  [1]Ali S, et al. Targeting the 5-HT2A Receptor for Developing Psychedelic Drugs and Beyond. J Med Chem. 2025 May 22;68 (10) :9831-9835.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• Isoform:

  5-HT2 Receptor